Indivior Pharmaceuticals, Inc <INDV.O>: Barclays cuts target price to $43 from $46
INDV•Related News
BP: Mizuho raises target price to $53 from $51
BP•
Zimmer Biomet Q2 revenue beats on technology, data growth
ZBH•
BorgWarner forecasts 2026 net sales of $14 billion-$14.3 billion
BWA•
Chimera Q2 FY26 turns to GAAP net loss of USD 4 million; earnings available for distribution slips to USD 39 million
CIM•
Infosys expands strategic partnership with Finland’s Metsä Group to accelerate AI-led IT transformation
INFY•